A detailed history of Seven Eight Capital, LP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 9,872 shares of MEDP stock, worth $3.44 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
9,872
Previous 4,906 101.22%
Holding current value
$3.44 Million
Previous $2.02 Million 62.97%
% of portfolio
0.31%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$320.58 - $457.29 $1.59 Million - $2.27 Million
4,966 Added 101.22%
9,872 $3.29 Million
Q2 2024

Aug 12, 2024

SELL
$372.0 - $424.34 $747,348 - $852,499
-2,009 Reduced 29.05%
4,906 $2.02 Million
Q1 2024

May 13, 2024

BUY
$284.87 - $413.31 $1.97 Million - $2.86 Million
6,915 New
6,915 $2.79 Million
Q4 2019

Feb 13, 2020

SELL
$70.08 - $84.64 $591,685 - $714,615
-8,443 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.38 - $85.89 $526,674 - $725,169
8,443 New
8,443 $710,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.